Company Shares of DexCom (NASDAQ:DXCM) Drops by -0.89%

DexCom (NASDAQ:DXCM) has risen sharply, recording gains of 9.68% in the past 4 weeks. However, the stock has corrected -0.89% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 7.94% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.

The company shares have dropped -3.83% from its 1 Year high price. On Sep 17, 2015, the shares registered one year high at $103.29 and the one year low was seen on Feb 8, 2016. The 50-Day Moving Average price is $72.45 and the 200 Day Moving Average price is recorded at $68.63.

The stock has recorded a 20-day Moving Average of 3.56% and the 50-Day Moving Average is 14.15%.


DexCom (NASDAQ:DXCM): stock turned positive on Friday. Though the stock opened at $79, the bulls momentum made the stock top out at $79 level for the day. The stock recorded a low of $77.29 and closed the trading day at $78.87, in the green by 0.84%. The total traded volume for the day was 1,068,802. The stock had closed at $78.21 in the previous days trading.

In an insider trading activity, The Securities and Exchange Commission has divulged that Moy Jeffrey, Officer (Svp, Operations) of DEXCOM INC, had unloaded 4,557 shares at an average price of $80 in a transaction dated on June 29, 2016. The total value of the transaction was worth $364,560.

Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products consist of DexCom G4, DexCom G4 PLATINUM and DexCom Share System. The DexCom G4 PLATINUM with Share uses a wireless connection between a patients receiver and an application on the patients iPhone to transmit glucose information to applications on the mobile devices of up to five designated recipients or followers, who can remotely monitor a patients glucose information and receive alert notifications anywhere they have an Internet connection. SweetSpots data transfer service is a Medical Device Data System (MDDS) and allows researchers to control the transfer of data from certain diabetes devices to research tools and databases according to their own research workflows.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.